Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty

Conditions:   Total Knee Arthroplasty;   Pain, Postoperative;   Adductor Canal Block
Interventions:   Procedure: Multimodal Peripheral Nerve Block Injection;   Procedure: Single Shot Adductor Canal Block
Sponsor:   Wake Forest School of Medicine
Not yet recruiting – verified December 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

Condition:   Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Treatment A – AZD7594;   Drug: Treatment B – AZD7594;   Drug: Treatment C – AZD7594
Sponsor:   AstraZeneca
Not yet recruiting – verified October 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

Condition:   Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Treatment A – AZD7594;   Drug: Treatment B – AZD7594;   Drug: Treatment C – AZD7594
Sponsor:   AstraZeneca
Not yet recruiting – verified October 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Condition:   Bronchial Asthma
Interventions:   Drug: Intravenous magnesium sulfate;   Drug: Inhaled budesonide;   Drug: normal saline
Sponsor:   Hamad Medical Corporation
Recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma

Conditions:   Healthy;   Asthma
Interventions:   Drug: JNJ-43260295;   Drug: Placebo;   Other: Nasal Allergen Challenge
Sponsor:   Janssen Research & Development, LLC
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Condition:   Duchenne’s Muscular Dystrophy
Intervention:   Biological: Umbilical Cord Mesenchymal Stem Cells
Sponsors:   Allergy and Asthma Consultants, Wichita, KansasAidan Foundation;   Neil H. Riordan PhDAllergy and Asthma Consultants, Wichita, Kansas
Enrolling by invitation – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Single Genetic Glitch May Explain Most Allergies and Asthma – TIME


Science World Report

Single Genetic Glitch May Explain Most Allergies and Asthma
TIME
Allergies are certainly the result of both genetic and environmental factors, but there is fresh evidence to suggest that at least one major genetic aberration could be behind everything from hay fever to food allergies to asthma. Allergies — to dust
Mutations linked to allergies, asthmaThe Japan Times
Scientists Uncover Genetic Glitch Responsible for AllergiesScience World Report
Study of genetic condition may yield clues to cause of allergiesMyFox Austin

all 5 news articles »

View full post on asthma – Google News